开普检测(003008) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 30,508,767.51, a decrease of 13.53% compared to CNY 35,281,597.38 in the same period last year[4] - Net profit attributable to shareholders was CNY 13,476,415.75, down 30.47% from CNY 19,381,194.52 year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 9,833,326.50, reflecting a decline of 40.91% compared to CNY 16,641,892.92 in the previous year[4] - Basic and diluted earnings per share were both CNY 0.17, down 29.17% from CNY 0.24 in the previous year[4] - Operating profit fell by 31.02% to CNY 15,671,836.38 from CNY 22,718,468.18, primarily due to a decline in revenue caused by the pandemic and rising operational costs[8] - Total profit of CNY 15,692,836.61, down 31.20% from CNY 22,808,564.73 in the previous year[8] - Net profit for the quarter was CNY 13,476,415.75, down from CNY 19,381,194.52 in the same period last year, representing a decline of approximately 30.4%[17] - The net profit attributable to the parent company for Q1 2022 was CNY 13,476,415.75, a decrease of 30.5% compared to CNY 19,381,194.52 in Q1 2021[18] Cash Flow - The net cash flow from operating activities was CNY 7,294,229.13, a decrease of 33.37% from CNY 10,948,002.42 in the same period last year[4] - The net cash flow from operating activities decreased by 33.37% to CNY 7,294,229.13, primarily due to reduced customer payments[8] - Cash flow from operating activities for Q1 2022 was CNY 7,294,229.13, a decline of 33.5% from CNY 10,948,002.42 in Q1 2021[21] - The net cash flow from investment activities for Q1 2022 was CNY 339,095,568.02, significantly higher than CNY 57,218,874.99 in Q1 2021[22] - The net increase in cash and cash equivalents for Q1 2022 was CNY 346,389,797.15, compared to CNY 68,166,877.41 in Q1 2021[22] - The ending balance of cash and cash equivalents as of Q1 2022 was CNY 492,240,252.56, up from CNY 314,590,856.37 at the end of Q1 2021[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,073,779,908.25, a slight decrease of 0.45% from CNY 1,078,585,282.66 at the end of the previous year[4] - Current assets totaled CNY 667,839,649.10, a slight decrease from CNY 679,053,843.70 at the start of the year[12] - Non-current assets increased to CNY 405,940,259.15 from CNY 399,531,438.96, indicating a growth of approximately 1.1%[13] - Total liabilities decreased to CNY 40,044,771.71 from CNY 58,326,561.87, reflecting a significant reduction in financial obligations[14] Expenses - Research and development expenses increased by 36.56% to CNY 2,445,344.53, indicating a rise in investment in R&D activities[7] - Management expenses rose by 37.32% to CNY 5,128,077.43, attributed to increased operational costs including labor and intermediary fees[7] - Total operating costs increased to CNY 19,059,464.69 from CNY 15,559,572.94, with operating costs rising from CNY 9,566,361.87 to CNY 10,098,149.05[17] - The company's financial expenses decreased by 56.09% to CNY -586,808.65, mainly due to reduced interest income[8] - The total tax expense decreased by 35.33% to CNY 2,216,420.86, reflecting the overall reduction in total profit[8] Investment Performance - The company reported a significant increase in cash and cash equivalents, with a 237.23% rise in monetary funds to CNY 492,448,727.56 due to the redemption of financial products and net inflow from operations[7] - Investment income surged by 139.70% to CNY 4,420,147.46, attributed to increased financial returns from concentrated redemptions of financial products[8] - The company reported an investment income of CNY 4,420,147.46, up from CNY 1,844,041.00 in the previous period, highlighting improved investment performance[17] Other Information - The company did not conduct any mergers or acquisitions during the reporting period[18]